Geographic · Sales to customers (Note 9)

Europe — Sales to customers (Note 9)

Johnson & Johnson Europe — Sales to customers (Note 9) increased by 4.5% to $5.85B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.4%, from $5.11B to $5.85B. Over 4 years (FY 2021 to FY 2025), Europe — Sales to customers (Note 9) shows relatively stable performance with a 1.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026Apr 22, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market share or demand in Europe, while a decrease suggests regional economic headwinds or competitive pressure.

Detailed definition

Represents the total revenue generated from external customers located within the European geographic region. This metri...

Peer comparison

Comparable to regional revenue disclosures provided by other multinational corporations in the pharmaceutical and medical device sectors.

Metric ID: jnj_segment_europe_sales_to_customers_note_9

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.67B$5.59B$3.93B$6.02B$6.09B$4.84B$5.12B$5.59B$5.13B$4.73B$4.96B$5.16B$5.21B$4.91B$4.92B$5.11B$5.39B$5.44B$5.60B$5.85B
QoQ Change-1.4%-29.7%+53.4%+1.0%-20.4%+5.8%+9.1%-8.2%-7.9%+5.0%+4.1%+1.0%-5.8%+0.1%+3.8%+5.4%+1.0%+2.9%+4.5%
YoY Change+7.4%-13.3%+30.5%-7.2%-15.7%-2.4%-3.2%-7.6%+1.6%+4.0%-0.8%-1.0%+3.3%+10.7%+13.8%+14.4%
Range$3.93B$6.09B
CAGR+0.7%
Avg YoY Growth+2.2%
Median YoY Growth+0.4%
Current Streak6 quarters growth

Frequently Asked Questions

What is Johnson & Johnson's europe — sales to customers (note 9)?
Johnson & Johnson (JNJ) reported europe — sales to customers (note 9) of $5.85B in Q1 2026.
How has Johnson & Johnson's europe — sales to customers (note 9) changed year-over-year?
Johnson & Johnson's europe — sales to customers (note 9) increased by 14.4% year-over-year, from $5.11B to $5.85B.
What is the long-term trend for Johnson & Johnson's europe — sales to customers (note 9)?
Over 4 years (2021 to 2025), Johnson & Johnson's europe — sales to customers (note 9) has grown at a 1.1% compound annual growth rate (CAGR), from $20.60B to $21.54B.
What does europe — sales to customers (note 9) mean?
Total revenue earned from customers located in Europe.